Summary
Cycle Pharmaceuticals Limited
Founded in 2012
Description
WHAT WE DO Cycle Pharmaceuticals is a global, privately-owned and patient-dedicated biotechnology company headquartered in Cambridge in the UK. Our mission is to utilise the latest pharmaceutical technologies to deliver superior drug treatments to b...
Strengths
- Cycle Pharmaceuticals Limited has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Cycle Pharmaceuticals Limited was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Annual Revenue
Cycle Pharmaceuticals Limited's annual revenue
$5415000
Based on Kona Equity data
-
Revenue per employee
$225625
-
Variance of revenue growth
0.06
-
Annual revenue growth since founding
$451250
-
Revenue growth rate from first known quarter to current
-27.3%
Employee Count
24 employees
-
Employee growth rate from first known quarter to current
-25.5%
Executives
Alice Clarkson
Legal Counsel
a**@cyclepharma.comAdriene Jarrell
Director, Sales (East)
a**@cyclepharma.comJohn Reid
Director, Patient HUB Services
j**@cyclepharma.comPaul Breen
Head of Finance (US)
p**@cyclepharma.comStaci Hagood
Director, Clinical Metabolic
s**@cyclepharma.comFrank Buchanan
Account Manager, Rare Disease
f**@cyclepharma.comRachal Soares
HUB Access Program Lead Specialist
r**@cyclepharma.comNoah Sachs
Legal Counsel
n**@cyclepharma.comPeter Myrenfors
Chief Medical Officer
p**@cyclepharma.comG Score - 7
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
2.64 M
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Cycle Pharmaceuticals Limited
- Category: Pharmaceuticals
- Industry: Pharmaceutical Company
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Boston Small Pharmaceutical Company in Boston Mid-size Pharmaceutical Company in Boston Pharmaceuticals in Boston Small Pharmaceuticals in Boston Mid-size Pharmaceuticals in Boston
-
By State MA Small companies in MA Pharmaceuticals in MA Small Pharmaceuticals in MA Mid-size Pharmaceuticals in MA Small Pharmaceutical Company in MA Mid-size Pharmaceutical Company in MA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Pharmaceutical Company Small Pharmaceutical Company Mid-size Pharmaceutical Company Pharmaceuticals and Pharmaceutical Company
-
Firmographic data G Score of 7 Founded in 2012 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare
Frequently Asked Questions
Cycle Pharmaceuticals Limited's headquarters are located at 200 Portland St., MA 10TH FL Boston, MA 02114.
Cycle Pharmaceuticals Limited's official website is cyclepharma.com
Cycle Pharmaceuticals Limited's annual revenue is $5.4 M.
Cycle Pharmaceuticals Limited's SIC: 2834; 283
Cycle Pharmaceuticals Limited's NAICS: 32541; 3254.
Cycle Pharmaceuticals Limited has 24 employees
Cycle Pharmaceuticals Limited is in the industry of Pharmaceuticals.